Gilead (GILD -0.7%) has a bit of a data dump from studies of its HIV treatments, highlighting...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

Gilead (GILD -0.7%) has a bit of a data dump from studies of its HIV treatments, highlighting good performances from elvitegravir, complera and cobicistat. Gilead is presenting the data at the 19th International AIDS Conference in Washington.